Holen Sie sich die Stockscreener-App
1.14
4.20%
-0.05
Handel nachbörslich:
1.15
0.01
+0.88%
Renovorx Inc Aktie (RNXT) Neueste Nachrichten
A director receives 55,924 RenovoRx (RNXT) stock options exercisable at $1.55 per share. - Stock Titan
A director receives 55,924 RenovoRx (RNXT) stock options with a $1.55 exercise price. - Stock Titan
55,924 options with a $1.55 exercise price go to RenovoRx (RNXT) director Robert J. Spiegel. - Stock Titan
RenovoRx (RNXT) grants Laurence Marton 55,924 stock options with a $1.55 exercise price. - Stock Titan
CFO of RenovoRx (RNXT) awarded 80,000 RSUs - Stock Titan
RenovoRx Inc. (RNXT) Falls 6.15% to $2.24 as Stock Approaches Key Support LevelCommon Gap - careplusvn.com
$RenovoRx (RNXT.US)$ - Moomoo
$RenovoRx (RNXT.US)$ - Moomoo
RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th - Investing News Network
RenovoRx H.C. Wainwright Presentation to Highlight RenovoCath Growth and Phase III TIGeR-PaC Timeline - Yahoo Finance
RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th - Yahoo Finance
Biotech Stocks At 52-Week HighsRNXT +15%, EOLS, CRNX, APGE - RTTNews
RenovoRx publishes pharmacokinetic data from Phase III trial By Investing.com - Investing.com Canada
RenovoRx publishes pharmacokinetic data from Phase III trial By Investing.com - Investing.com UK
RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic Data Supporting TAMP Platform's Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer - Investing News Network
Transcript : RenovoRx, Inc., Q2 2026 Earnings Call, Aug 12, 2026 - marketscreener.com
RenovoRx (RNXT) Earnings Update: Reported EPS Tops Expectations at the Close; Post-Report: The Stock Finishes Near Unchanged in the Latest SessionShort-Term Outlook - vinanet.vn
RenovoRx (NASDAQ:RNXT) Gains Attention After Compliance Update - Kalkine Media
RenovoRx regains Nasdaq minimum bid price compliance - Investing.com
RenovoRx regains Nasdaq minimum bid price compliance By Investing.com - Investing.com UK
RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement - Yahoo! Finance Canada
RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times
RenovoRx Regains Nasdaq Compliance on Minimum Bid Price - The Globe and Mail
RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment - Investing News Network
RenovoRx receives U.S. patent allowance for cancer device - Investing.com
RenovoRx receives U.S. patent allowance for cancer device By Investing.com - Investing.com Canada
RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath, an Advanced Dual-Occlusion Catheter for Targeted Therapeutic Drug-Delivery for Cancer Treatment - marketscreener.com
RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment - The Manila Times
RenovoRx Regains Nasdaq Compliance on Minimum Bid Price - TipRanks
RenovoRx Advances Targeted Localized Therapy for Advanced Pancreatic Cancer - geneonline.com
HC Wainwright Has Positive Outlook of RenovoRx Q3 Earnings - MarketBeat
RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers - sharewise.com
What is HC Wainwright's Forecast for RenovoRx Q3 Earnings? - MarketBeat
RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers - MarketBeat
RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers - Yahoo Finance
RenovoRx (RNXT) Q2 2026 Earnings: Narrower-than-Expected Loss Drives 11% Share RallyForward Guidance Trends - vinanet.vn
RNXT Q2 2026 Earnings: Narrower Loss Beats Estimate, Shares Jump 11%Share Dilution Risk - vinanet.vn
RenovoRx (NASDAQ:RNXT) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Renovorx Stock Price Forecast. Should You Buy RNXT? - StockInvest.us
H.C. Wainwright Maintains RenovoRx(RNXT.US) With Buy Rating, Maintains Target Price $3 - Moomoo
RenovoRx Inc (NASDAQ: RNXT) Stock Price, News & Analysis - kalkine.ca
RenovoRx Inc (NASDAQ: RNXT) Stock Price, News & Analysis - Kalkine
RenovoRx earnings beat by $0.02, revenue topped estimates - Investing.com Nigeria
RenovoRx earnings beat by $0.02, revenue topped estimates - Investing.com Canada
RenovoRx Inc (RNXT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Expansion ... - Yahoo Finance
RenovoRx, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
RenovoRx Q2 Earnings Call Highlights - MarketBeat
RenovoRx Q2 Earnings Call Highlights - Yahoo Finance
RenovoRx earnings beat by $0.02, revenue topped estimates - Investing.com
RenovoRx (RNXT) Q2 2026 Earnings Call Transcript - AOL.com
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):